KRAS and leukemia: The mutation frequency of known CBF leukemia associated genes was similar to previous reports [3–6, 8]; Most common were missense mutations of RAS-genes, present in 57% of the patients (43% NRAS, 19% KRAS), affecting the known hotspots (G12, G13, Q61).